SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-236536
Filing Date
2018-08-02
Accepted
2018-08-02 16:04:31
Documents
94
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d581454d10q.htm 10-Q 1295460
2 EX-31.1 d581454dex311.htm EX-31.1 11169
3 EX-31.2 d581454dex312.htm EX-31.2 11248
4 EX-32 d581454dex32.htm EX-32 4816
  Complete submission text file 0001193125-18-236536.txt   8597078

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT teva-20180630.xml EX-101.INS 2012668
6 XBRL TAXONOMY EXTENSION SCHEMA teva-20180630.xsd EX-101.SCH 90983
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE teva-20180630_cal.xml EX-101.CAL 98163
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE teva-20180630_def.xml EX-101.DEF 483042
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20180630_lab.xml EX-101.LAB 604564
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20180630_pre.xml EX-101.PRE 566794
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16174 | Film No.: 18988212
SIC: 2834 Pharmaceutical Preparations